Daily FNArena News - Small Caps
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure ChestPrevious Stories
Avita Medical Preps For Enlarged US Opportunity
May 17 2023
Brokers review first quarter results and pending regulatory approvals for Avita Medical
Judo Capital Offers Differentation
May 11 2023
Brokers continue to rate Judo Capital highly despite looming macroeconomic headwinds
Dr Boreham’s Crucible: Impedimed
May 08 2023
Tim Boreham reports a change in CEO has given cancer monitoring biotech Impedimed a new lease of life
Artificial Intelligence On The ASX
May 02 2023
The ASX-listed AI sector can be split between tech providers developing AI tools and non-tech companies using AI to improve their existing business
Dr Boreham’s Crucible: Volpara Health Technologies
Apr 26 2023
Volpara Health Technologies is revolutionising breast cancer detection. Tim Boreham investigates
Dr Boreham’s Crucible: Radiopharm Theronostics
Apr 13 2023
Cancer detection biotech Radiopharm Theronostics is planning to list on the Nasdaq, and not without good reason, Tim Boreham explains
Cybersecurity On The ASX
Apr 11 2023
It’s impossible to picture a future without cybersecurity. The ASX hosts a smorgasboard in potential exposures
Dr Boreham’s Crucible: Avita Medical
Mar 29 2023
Tim Boreham highlights the global addressable market opportunity for Avita Medical’s skin graft technology, made famous by the Bali bombings
Helloworld Turnaround Now Includes Europe
Mar 28 2023
Tapping into the Scandinavian market, Helloworld has acquired an interest in Norway-based Australiareiser, bringing its ResWorld platform to Europe
Telix Pharmaceuticals’ Pipeline Full Of Promise
Mar 21 2023
Following FY22 results for Telix Pharmaceuticals brokers remain Buy-rated in light of an extensive pipeline of new products under development
